RECRUITING

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Official Title

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Quick Facts

Study Start:2023-04-03
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05657990

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Males
  2. * ≥55 years old
  3. * Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.
  4. * Surgery scheduled more than 7 days from the time of consent
  1. * Using Tamsulosin already
  2. * Known allergy to Tamsulosin or sulfa drugs
  3. * Current use of Boceprevir
  4. * Resting systolic blood pressure \<100
  5. * Orthostatic hypotension of \>20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consent
  6. * Known history of hypotension
  7. * Known diagnosis of congestive heart failure (CHF) and valvular heart disease
  8. * History of prior prostate surgery (prostatectomy, trans-urethral resection)

Contacts and Locations

Study Contact

Denise Theiler, RN
CONTACT
7327763301
Denise.Theiler@hmhn.org

Principal Investigator

Thomas Bauer, MD
PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health

Study Locations (Sites)

Ocean University Medical Center
Brick, New Jersey, 08724
United States
South Ocean University Medical Center
Manahawkin, New Jersey, 08050
United States
Jersey Shore University Medical Center
Neptune, New Jersey, 07753
United States
Riverview Medical Center
Red Bank, New Jersey, 07701
United States

Collaborators and Investigators

Sponsor: Hackensack Meridian Health

  • Thomas Bauer, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-03
Study Completion Date2026-12

Study Record Updates

Study Start Date2023-04-03
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • Urinary Retention
  • post surgery Urinary Retention
  • thoracic surgery
  • spontaneous voiding
  • bladder retention
  • Tamsulosin (FlomaxTM)
  • kidney injury
  • men undergoing thoracic oncological surgical procedure
  • BladderScanner

Additional Relevant MeSH Terms

  • Urinary Retention